These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Chemotherapy and targeted therapy combinations in advanced melanoma. Flaherty KT Clin Cancer Res; 2006 Apr; 12(7 Pt 2):2366s-2370s. PubMed ID: 16609060 [TBL] [Abstract][Full Text] [Related]
4. Management of metastatic melanoma 2005. O'Day S; Boasberg P Surg Oncol Clin N Am; 2006 Apr; 15(2):419-37. PubMed ID: 16632224 [TBL] [Abstract][Full Text] [Related]
5. Biochemotherapy of melanoma. Keilholz U Forum (Genova); 2003; 13(2):158-65; quiz 189. PubMed ID: 14732882 [TBL] [Abstract][Full Text] [Related]
6. Interleukin-2 for the treatment of melanoma. Tarhini AA; Agarwala SS Curr Opin Investig Drugs; 2005 Dec; 6(12):1234-9. PubMed ID: 16370388 [TBL] [Abstract][Full Text] [Related]
7. Prognostic factors in metastatic melanoma patients treated with biochemotherapy and maintenance immunotherapy. Minor DR; Moore D; Kim C; Kashani-Sabet M; Venna SS; Wang W; Boasberg P; O'Day S Oncologist; 2009 Oct; 14(10):995-1002. PubMed ID: 19776094 [TBL] [Abstract][Full Text] [Related]
8. Systemic therapy for unresectable metastatic melanoma: impact of biochemotherapy on long-term survival. Bedikian AY; Johnson MM; Warneke CL; McIntyre S; Papadopoulos N; Hwu WJ; Kim K; Hwu P J Immunotoxicol; 2008 Apr; 5(2):201-7. PubMed ID: 18569391 [TBL] [Abstract][Full Text] [Related]
9. Cutaneous melanoma: available therapy for metastatic disease. Tarhini AA; Agarwala SS Dermatol Ther; 2006; 19(1):19-25. PubMed ID: 16405566 [TBL] [Abstract][Full Text] [Related]
10. Chemotherapy compared with biochemotherapy for the treatment of metastatic melanoma: a meta-analysis of 18 trials involving 2,621 patients. Ives NJ; Stowe RL; Lorigan P; Wheatley K J Clin Oncol; 2007 Dec; 25(34):5426-34. PubMed ID: 18048825 [TBL] [Abstract][Full Text] [Related]
11. Chemotherapy for metastatic melanoma. Mandarà M; Nortilli R; Sava T; Cetto GL Expert Rev Anticancer Ther; 2006 Jan; 6(1):121-30. PubMed ID: 16375649 [TBL] [Abstract][Full Text] [Related]
12. Complex combination biochemotherapy regimen in advanced metastatic melanoma in a non-intensive care unit: toxicity or benefit? Hofmann MA; Sterry W; Trefzer U Jpn J Clin Oncol; 2007 Mar; 37(3):224-9. PubMed ID: 17472972 [TBL] [Abstract][Full Text] [Related]
13. Individualized therapy of disseminated cancer using malignant melanoma as a model. Hauschild A; Egberts F; Russo P; Kähler KC Cancer Metastasis Rev; 2006 Jun; 25(2):253-6. PubMed ID: 16770537 [TBL] [Abstract][Full Text] [Related]
14. Biochemotherapy in patients with advanced head and neck mucosal melanoma. Bartell HL; Bedikian AY; Papadopoulos NE; Dett TK; Ballo MT; Myers JN; Hwu P; Kim KB Head Neck; 2008 Dec; 30(12):1592-8. PubMed ID: 18798304 [TBL] [Abstract][Full Text] [Related]
16. Systemic treatment of malignant melanoma. Mota A; Deisseroth A Clin Plast Surg; 2000 Jul; 27(3):463-74, x. PubMed ID: 10941566 [TBL] [Abstract][Full Text] [Related]
17. Re-evaluating the role of dacarbazine in metastatic melanoma: what have we learned in 30 years? Eggermont AM; Kirkwood JM Eur J Cancer; 2004 Aug; 40(12):1825-36. PubMed ID: 15288283 [TBL] [Abstract][Full Text] [Related]
18. The use of interleukins for advanced melanoma. Miller SJ Skin Therapy Lett; 2001; 6(4):3-5. PubMed ID: 11176044 [TBL] [Abstract][Full Text] [Related]
19. Treatments for metastatic melanoma: synthesis of evidence from randomized trials. Lui P; Cashin R; Machado M; Hemels M; Corey-Lisle PK; Einarson TR Cancer Treat Rev; 2007 Dec; 33(8):665-80. PubMed ID: 17919823 [TBL] [Abstract][Full Text] [Related]
20. Outcomes following isolated limb infusion for melanoma. A 14-year experience. Kroon HM; Moncrieff M; Kam PC; Thompson JF Ann Surg Oncol; 2008 Nov; 15(11):3003-13. PubMed ID: 18509706 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]